| RS886043877 |
PEX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS886043881 |
TRIM32
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS886043882 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS886043884 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886043888 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043896 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886043900 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886043901 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886043903 |
HNF1B
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Renal cysts and diabetes syndrome |
| RS886043904 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS886043908 |
PEX6
|
Health Risk |
Pathogenic |
— |
| RS886043909 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043919 |
COL6A3
|
Health Risk |
Likely pathogenic |
Ullrich congenital muscular dystrophy 1A, Bethlem myopathy 1A |
| RS886043920 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS886043923 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS886043924 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886043926 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS886043927 |
PLOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS886043929 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS886043932 |
CPAP
|
Health Risk |
Pathogenic |
— |
| RS886043934 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS886043935 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS886043936 |
SOX2
|
Health Risk |
Pathogenic |
— |
| RS886043938 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS886043945 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886043948 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2K |
| RS886043951 |
DNAJB6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) |
| RS886043955 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886043958 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS886043959 |
FKRP
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS886043962 |
SGCA
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS886043963 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS886043964 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886043966 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS886043974 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS886043979 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
GNE myopathy, Sialuria |
| RS886043984 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 1A (Zellweger), Zellweger spectrum disorders |
| RS886043986 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886043987 |
PEX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 4A (Zellweger), Peroxisome biogenesis disorder 4A (Zellweger) |
| RS886043989 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Neuromuscular disease caused by qualitative or quantitative defects of dystrophin |
| RS886043990 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Colon adenocarcinoma |
| RS886043992 |
COL6A3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886043993 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Bethlem myopathy 1A |
| RS886043994 |
ASXL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS886044002 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS886044003 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS886044004 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS886044005 |
NEB
|
Health Risk |
Pathogenic |
— |
| RS886044009 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886044010 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886044012 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS886044013 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886044017 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS886044020 |
ANO5
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS886044023 |
COL6A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886044028 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy |
| RS886044030 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886044031 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Duchenne muscular dystrophy |
| RS886044034 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886044035 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS886044049 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Cardiomyopathy |
| RS886044051 |
SMARCAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS886044052 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS886044057 |
ZMPSTE24
|
Health Risk |
Pathogenic |
— |
| RS886044058 |
CSPP1
|
Health Risk |
Pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS886044059 |
TBX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS886044060 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS886044062 |
ACTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886044069 |
DNAJB6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) |
| RS886044074 |
IHH
|
Health Risk |
Conflicting classifications of pathogenicity |
IHH-Related Disorders, IHH-Related Disorders |
| RS886044076 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886044077 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886044078 |
DES
|
Health Risk |
Conflicting classifications of pathogenicity |
Desmin-related myofibrillar myopathy, Cardiovascular phenotype |
| RS886044081 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS886044083 |
FKRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2I, Walker-Warburg congenital muscular dystrophy |
| RS886044085 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886044088 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886044091 |
SLC27A5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886044096 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS886044103 |
SGCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS886044106 |
TRIM32
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, TRIM32-related disorder |
| RS886044109 |
COL1A2
|
Health Risk |
Likely pathogenic |
— |
| RS886044111 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS886044113 |
MPV17
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Charcot-Marie-Tooth disease |
| RS886044116 |
PIGV
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasia with intellectual disability syndrome 1, Hyperphosphatasia with intellectual disability syndrome 1 |
| RS886044118 |
HEXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Sandhoff disease, Sandhoff disease |
| RS886044119 |
WDR35
|
Health Risk |
Pathogenic/Likely pathogenic |
SHORT-RIB THORACIC DYSPLASIA 7 WITHOUT POLYDACTYLY, Short rib-polydactyly syndrome |
| RS886044120 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886044121 |
CRX
|
Health Risk |
Pathogenic |
— |
| RS886044125 |
COL1A1
|
Health Risk |
Likely pathogenic |
— |
| RS886044126 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS886044129 |
SMCHD1
|
Health Risk |
Pathogenic |
— |
| RS886044131 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS886044132 |
SGCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Inborn genetic diseases |
| RS886044133 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS886044135 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS886044136 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS886044140 |
COL6A2
|
Health Risk |
Pathogenic |
— |
| RS886044141 |
STXBP1
|
Health Risk |
Pathogenic |
— |
| RS886044142 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |